Log In
Tuesday 20th March 2018

PSA tests lead to overdiagnosis

3rd August 2006

Further evidence has shown widespread screening for prostate cancer would result in massive overdiagnosis and treatment.

Researchers from Cambridge University and the Wolfson Institute of Preventive Medicine, report in the British Journal of Cancer, that more than half of cases who underwent the prediagnosis prostate specific antigen (PSA) test are likely to have been overdiagnosed. This means the cancer would not have been detected clinically in their lifetime without the PSA testing.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018